Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.63% | 21.66% | -35.91% | -48.72% | 58.30% |
| Total Depreciation and Amortization | -13.16% | 26.67% | 3.45% | -23.68% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.83% | 136.13% | -83.35% | 614.46% | -65.32% |
| Change in Net Operating Assets | 188.77% | -263.69% | 145.44% | 7.41% | -176.60% |
| Cash from Operations | 26.66% | 8.03% | -28.80% | -8.89% | 27.77% |
| Capital Expenditure | -- | -- | 100.00% | -41.56% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -340.01% | -150.73% | 66.17% | 216.04% | 111.38% |
| Cash from Investing | -342.01% | -150.73% | 67.35% | 218.85% | 111.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,073,960.00% | -92.31% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,073,960.00% | 123.81% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.34% | -376.55% | 216.63% | 149.24% | 89.11% |